The Motley Fool··Parkev Tatevosian, CfaEli Lilly's Mounjaro Momentum: Is $LLY Trading Below Fair Value?
Eli Lilly's Mounjaro-driven growth supports strong fundamentals, but whether $LLY stock at $1,065.96 represents undervaluation depends on competitive durability assumptions.
LLYstock valuationweight loss drugs